A randomized double-blind 12-week study of quetiapine, risperidone or fluphenazine on sexual functioning in people with schizophrenia

Psychoneuroendocrinology

Volumn 31, Issue 3, 2006, Pages 340-346

  Kelly, Deanna L ^a   Conley, Robert R ^a  

^a MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

Author keywords

Antipsychotics; Prolactin; Schizophrenia; Sexual dysfunction

Indexed keywords

FLUPHENAZINE; PROLACTIN; QUETIAPINE; RISPERIDONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GALACTORRHEA; GYNECOMASTIA; HUMAN; MALE; MENSTRUATION DISORDER; ORGASM; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; SEXUAL DYSFUNCTION; SEXUALITY;

ADULT; ANALYSIS OF VARIANCE; ANTIPSYCHOTIC AGENTS; DIBENZOTHIAZEPINES; DOUBLE-BLIND METHOD; FEMALE; FLUPHENAZINE; HUMANS; MALE; MIDDLE AGED; ORGASM; PATIENT COMPLIANCE; PROLACTIN; RISPERIDONE; SCHIZOPHRENIA; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

EID: 32944461855     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2005.08.010     Document Type: Article

References (38)

1. G. Abraham, U. Halbreich, R.H. Friedman, and R.C. Josiassen Bone mineral density and prolactin associations in patients with chronic schizophrenia Schizophr Res. 59 1 2003 17 18
2. D. Aizenberg, Z. Zemishlany, P. Dorfman-Etrog, and A. Weizman Sexual dysfunction in male schizophrenic patients J. Clin. Psychiatry. 56 1995 137 141
3. D. Aizenberg, I. Modai, A. Landa, I. Gil-Ad, and A. Weizman Comparison of sexual dysfunction in male schizophrenic patients maintained on treatment with classical antipsychotics versus clozapine J. Clin. Psychiatry. 62 2001 541 544
4. S. Akhtar, and J. Thomson Schizophrenia and sexuality: a report of twelve unusual cases-part I J. Clin. Psychiatry. 41 1980 134 142
5. L. Arvenitis, and B. Miller Study Group, Multiple fixed doses of Seroquel (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo Biol. Psychiatry. 42 4 1997 233 246
6. A.G. Awad, and L.N. Voruganti New antipsychotics, compliance, quality of life and subjective tolerability-are patients better off? Can. J. Psychiatry. 49 2004 297 302
7. J. Bobes, J. Bobes, M.P. Garc A-Portilla, J. Rejas, G. Hernandez, M. Garcia-Garcia, F. Rico-Villademoros, and A. Porras Frequency of sexual dysfunction and other reproductive side-effects in patients with schizophrenia treated with risperidone, olanzapine, quetiapine, or haloperidol: the results of the EIRE study J. Sex. Marital. Ther. 29 2003 125 147
8. R.L. Borison, L.A. Arvanitis, and B.G. Miller ICI 204,636, An atypical antipsychotic: efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia J. Clin. Psychopharmacol. 16 2 1996 158 169
9. S. Brunellsechi, P. Zeppegno, F. Risso, C.I. Cattaneo, and E. Torre Risperidone-associated Hyperprolactinemia: evaluation in twenty psychiatric outpatients Pharmacol. Res. 48 2003 405 409
10. T. Burns, A. Floritti, F. Holloway, U. Malm, and W. Rossler Case management and assertive community treatment in Europe Psychiatr. Serv. 52 5 2001 631 636
11. A.H. Clayton, J.E. Owens, and E.L. McGarvey Assessment of paroxetine-induced sexual dysfunction using the changes in sexual functioning questionnaire Psychopharmacol Bull. 31 1995 397 406
12. Conley RR, Kelly DL, Nelson M, Richardson CM, Feldman S, Reynolds R, Steiner P, Yu Y, Khan I, McMullen R, Gale E, Mackowick M, Love R, December 2003. Risperidone and quetiapine vs. fluphenazine in treatment-resistant schizophrenia. Presented at the American College of Neuropsychopharmacology (ACNP), San Juan, Puerto Rico.
13. A.J. Cutler Sexual dysfunction and antipsychotic treatment Psychoneuroendocrinology. 28 2003 69 82
14. E.G. DeRenzo, R.R. Conley, and R.C. Love Assessment of Capacity to give consent to research participation: state-of-the-art and beyond J. Health Care Law Policy. 1 1 1998 66 87
15. M. Dossenbach, A. Hodge, M. Anders, B. Molnar, D. Peciukaitiene, I. Krupka-Matuszczyk, M. Tatu, V. Bondar, J. Pecenak, T. Gorjanc, and M. McBride Prevalence of sexual dysfunction in patients with schizophrenia: international variation and underestimation Int. J. Neuropsychopharmacol. 8 2005 195 201
16. W.W. Fleischhacker, U. Meise, V. Gunther, and M. Kurz Compliance with antipsychotic drug treatment: influence of side effects Acta Psychiatr Scand. 89 supp 89 1994 11 15
17. A.M. Ghadirian, G. Chouinard, and L. Annable Sexual dysfunction and plasma prolactin levels in neuroleptic-treated schizophrenic patients J. Nerv Ment Dis. 170 8 1982 463 467
18. P.M. Haddad, and A. Wieck Antipsychotic-induced Hyperprolactinemia: mechanisms, clinical features and management Drugs. 64 2004 2291 2314
19. S. Kapur, R. Zipursky, C. Jones, C.S. Shammi, G. Remington, and P. Seeman A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy Arch Gen Psychiatry. 57 2000 553 559
20. D.L. Kelly, and R.R. Conley Sexuality and schizophrenia: a review Schizophrenia Bulletin. 30 2005 767 779
21. D.J. King, C.G.G. Link, and B. Kowalcyk A comparison of bd and tid dose regimens of quetiapine (Seroquel) in the treatment of schizophrenia Psychopharmacology. 137 1998 139 146
22. D.L. Kleinberg, J.M. Davis, R. de Coster, B. Van Baelen, and M. Brecher Prolactin levels and adverse events in patients treated with risperidone J. Clin. Psychopharmacol. 19 1999 57 61
23. H. Knegtering, A.E. van der Moolen, S. Castelein, H. Kluiter, and R.J. van den Bosch What are the effects of antipsychotics on sexual dysfunctions and endocrine functioning Psychoneuroendocrinology 28 2003 109 123
24. R. Knegtering, S. Castelein, H. Bous, J. Van Der Linde, R. Bruggeman, H. Kluiter, and R.J. van den Bosch A randomized open-label study of the impact of quetiapine versus risperidone on sexual functioning J. Clin. Psychopharmacol. 24 2004 56 61
25. M. Lambert, P. Conus, P. Eide, R. Mass, A. Karrow, S. Moritz, D. Golks, and D. Naber Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence Eur. Psychiatry. 19 2004 415 422
26. J. Lewis, and E. Scott The sexual education needs of those disabled by mental illness Psychiatric Rehabilitation J. 21 1997 164 167
27. S. Macdonald, J. Halliday, T. MacEwan, V. Sharkey, S. Farrington, S. Wall, and R.G. McCreadie Nithsdale,Schizophrenia surveys 24: sexual dysfunctions. Case control study Br. J. Psychiatry. 182 2003 50 56
28. C.M. Meston, and L.R. Derogotis Validated instruments for assessing female sexual function J. Sex Marital Ther. 1 suppl 28 2002 155 164
29. V. O'Keane, and A.M. Meaney Antipsychotic drugs: a new risk factor for osteoporosis in young women with schizophrenia? J. Clin. Psychopharmacol 25 2005 26 31
30. D.O. Perkins Predictors of noncompliance in patients with schizophrenia J. Clin. Psychiatry. 63 2002 1121 1128
31. A.J. Riley, and E.J. Riley Evaluation of drug effects on human sexual dysfunction A.J. Riley M. Peet C. Wilson Sexual pharmacology 1993 Claredon Oress Oxford 114 129
32. M. Ritsner, G. Perelroyzen, H. Han, and A. Gibel Subjective response to antipsychotics of schizophrenia patients treated in routine clinical practice: a naturalistic compartive study J. Clin. Psyhcopharmacol. 24 2004 245 254
33. G. Rozan, T. Tuchin, and M. Kurland Some implications of sexual activity for mental illness Mental Hygiene. 55 1971 318 323
34. J.G. Small, S.R. Hirsch, L.A. Arvanitis, B.G. Miller, and C.G. Link Quetiapine in patients with schizophrenia: a high- and low-dose double-blind comparison with placebo Arch Gen Psychiatry. 54 6 1997 549 557
35. S.M. Smith, V. O'Keane, and R. Murray Sexual dysfunction in patients taking conventional antipsychotic medication Br. J. Psychiatry. 181 2002 49 55
36. S. Smith Effects of antipsychotics on sexual and endocrine function in women: implications for clinical practice J. Clin. Psychopharmacol. 23 3 suppl 1 2003 S27 S32
37. G. Sullivan, and D. Lukoff Sexual side effects of antipsychotic mediation: evaluation and interventions Hospital Community Psychiatry. 41 1990 1238 1241
38. P. Turrone, S. Kapur, M.V. Seeman, and A.J. Flint Elevation of prolactin levels by atypical antipsychotics Am. J. Psychiatr. 159 2002 133 135